25 Apr Nashville lab ramps up xylazine testing increasingly detected in drug overdoses
Posted at 19:10h
in News
The Biden Administration recently designated the fentanyl-xylazine combination as an emerging national threat. Aegis Sciences Corporation in Nashville has been on the forefront of testing for the deadly compound. Dr. Josh Schrecker, senior director of clinical affairs talked with NewsChannel 5 about how providers utilize test results. Early identification of these compounds is key to appropriate treatment and reduction of overdose risk.
Nashville lab ramps up xylazine testing increasingly detected in drug overdoses
To read the full story, please visit www.newschannel5.com.